ArticleDiabetes technology & therapeutics2026
Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes.
Article in Diabetes technology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveWe compared long-term, real-world glycemic outcomes and device engagement in U.S. youth with type 1 diabetes (T1D) using two automated insulin delivery (AID) systems.
methodsWe included youth (ages 6-18) with T1D from a large academic center who started on Insulet Omnipod 5 (OP5) or Tandem Control IQ (CIQ) between January 2020 and June 2024. We collected 30-day continuous glucose monitor and 30-day AID data at baseline and 3, 6, 12, and 18 months following AID initiation. We evaluated change in glycemic metrics and user behaviors (e.g., self-initiated bolusing and carbohydrate entry) by system using separate multivariable linear regression models at each time point while adjusting for baseline factors (age, sex, insulin regimen prior to AID initiation, diabetes duration, and baseline values for the respective glycemic metric).
resultsAll AID users (
conclusionsAlthough glycemic outcomes are similar between devices over 18 months, AID user engagement changes with time and differs between systems, potentially as they "trust" their device more. Change in carbohydrate entry among CIQ users is likely a major contributor to the decline in TIR with longer duration of AID use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.